AMISHI DESAI NPI 1902141914

NPI Details

Amishi Desai is a hematology and oncology internal medicine in Port Jefferson Station, NY with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Amishi Desai NPI is 1902141914. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1500 ROUTE 112 BLDG 4
PORT JEFFERSON STATION, NY
ZIP 11776-055
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1902141914 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Vitamin d-3 level (HCPCS:82306)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, manual test (HCPCS:85044)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Hemoglobin a1c level (HCPCS:83036)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Testosterone (hormone) level, total (HCPCS:84403)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Bilirubin level, total (HCPCS:82247)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Urinalysis, manual test (HCPCS:81002)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Acute hepatitis panel (HCPCS:80074)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Bilirubin level, direct (HCPCS:82248)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Rheumatoid factor level (HCPCS:86431)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Ige (immune system protein) level (HCPCS:82785)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)

The enumeration date for this NPI number is 12/2/2012 and was last updated on 12/2/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: